Background: Deep brain stimulation (DBS) at the subthalamic nucleus (STN) or globus pallidus internus (GPi) can effectively treat the motor symptoms of Parkinson's disease, but dual implantation is rare. We report the first cases of additional GPi stimulation as rescue therapy for disabling dyskinesias following successful STN stimulation. Methods: Two patients, initially treated with bilateral STN DBS, underwent subsequent bilateral GPi DBS after the development of refractory dyskinesias within 1 and 6 years of STN surgery. Patients were evaluated with the Unified Parkinson's Disease Rating Scale (UPDRS) before and after surgeries for STN and GPi DBS. Results: GPi DBS effectively suppressed dyskinesias in these patients and improved their quality of life, as demonstrated by their videos and UPDRS scores. Conclusions: Additional bilateral GPi DBS may be considered in the rare instance of patients who develop refractory dyskinesias early or late after bilateral STN DBS.

Keywords:
Deep brain stimulation, Parkinsonism, Subthalamic nucleus, Globus pallidus, Dyskinesia
1.
Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD: Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73.
2.
Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ: Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-2091.
3.
Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ: Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology 2012;79:55-65.
4.
Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Halbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltete D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Kruger R, Pinsker MO, Amtage F, Regis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G: Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013;368:610-622.
5.
Odekerken VJ, van Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, Beute GN, van Vugt JP, Lenders MW, Contarino MF, Mink MS, Bour LJ, van den Munckhof P, Schmand BA, de Haan RJ, Schuurman PR, de Bie RM: Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013;12:37-44.
6.
Peppe A, Pierantozzi M, Bassi A, Altibrandi MG, Brusa L, Stefani A, Stanzione P, Mazzone P: Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease. J Neurosurg 2004;101:195-200.
7.
Mazzone P, Brown P, Dilazzaro V, Stanzione P, Oliviero A, Peppe A, Santilli V, Insola A, Altibrandi M: Bilateral implantation in globus pallidus internus and in subthalamic nucleus in Parkinson's disease. Neuromodulation 2005;8:1-6.
8.
Houeto JL, Bejjani PB, Damier P, Staedler C, Bonnet AM, Pidoux B, Dormont D, Cornu P, Agid Y: Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD. Neurology 2000;55:728-730.
9.
Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ: Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol 2004;55:871-875.
10.
Allert N, Lehrke R, Sturm V, Volkmann J: Secondary failure after ten years of pallidal neurostimulation in a patient with advanced Parkinson's disease. J Neural Transm 2010;117:349-351.
11.
Deogaonkar M, Monsalve GA, Scott J, Ahmed A, Rezai A: Bilateral subthalamic deep brain stimulation after bilateral pallidal deep brain stimulation for Parkinson's disease. Stereotact Funct Neurosurg 2011;89:123-127.
12.
Wohrle JC, Blahak C, Capelle HH, Fogel W, Bazner H, Krauss JK: Combined pallidal and subthalamic nucleus stimulation in sporadic dystonia-parkinsonism. J Neurosurg 2012;116:95-98.
13.
Allert N, Schnitzler A, Sturm V, Maarouf M: Failure of long-term subthalamic nucleus stimulation corrected by additional pallidal stimulation in a patient with Parkinson's disease. J Neurol 2012;259:1244-1246.
14.
Houeto JL, Welter ML, Bejjani PB, Tezenas du Montcel S, Bonnet AM, Mesnage V, Navarro S, Pidoux B, Dormont D, Cornu P, Agid Y: Subthalamic stimulation in Parkinson disease: intraoperative predictive factors. Arch Neurol 2003;60:690-694.
15.
Benabid AL, Wallace B, Mitrofanis J, Xia C, Piallat B, Fraix V, Batir A, Krack P, Pollak P, Berger F: Therapeutic electrical stimulation of the central nervous system. C R Biol 2005;328:177-186.
16.
Herzog J, Pinsker M, Wasner M, Steigerwald F, Wailke S, Deuschl G, Volkmann J: Stimulation of subthalamic fibre tracts reduces dyskinesias in STN-DBS. Mov Disord 2007;22:679-684.
17.
Gago MF, Rosas MJ, Linhares P, Ayres-Basto M, Sousa G, Vaz R: Transient disabling dyskinesias: a predictor of good outcome in subthalamic nucleus deep brain stimulation in Parkinson's disease. Eur Neurol 2009;61:94-99.
18.
Zheng Z, Li Y, Li J, Zhang Y, Zhang X, Zhuang P: Stimulation-induced dyskinesia in the early stage after subthalamic deep brain stimulation. Stereotact Funct Neurosurg 2010;88:29-34.
19.
Carter DA, Parsai EI, Ayyangar KM: Accuracy of magnetic resonance imaging stereotactic coordinates with the Cosman-Roberts-Wells frame. Stereotact Funct Neurosurg 1999;72:35-46.
20.
Esselink RA, de Bie RM, de Haan RJ, Lenders MW, Nijssen PC, Staal MJ, Smeding HM, Schuurman PR, Bosch DA, Speelman JD: Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004;62:201-207.
21.
Calabresi P, Di Filippo M, Ghiglieri V, Tambasco N, Picconi B: Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. Lancet Neurol 2010;9:1106-1117.
22.
Fasano A, Romito LM, Daniele A, Piano C, Zinno M, Bentivoglio AR, Albanese A: Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain 2010;133:2664-2676.
23.
Merola A, Zibetti M, Angrisano S, Rizzi L, Ricchi V, Artusi CA, Lanotte M, Rizzone MG, Lopiano L: Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain 2011;134:2074-2084.
24.
Zibetti M, Merola A, Rizzi L, Ricchi V, Angrisano S, Azzaro C, Artusi CA, Arduino N, Marchisio A, Lanotte M, Rizzone M, Lopiano L: Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease. Mov Disord 2011;26:2327-2334.
25.
Bergman H, Deuschl G: Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord 2002;17(suppl 3):S28-S40.
26.
Boraud T, Bezard E, Bioulac B, Gross CE: Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain 2001;124:546-557.
27.
Lee JI, Verhagen Metman L, Ohara S, Dougherty PM, Kim JH, Lenz FA: Internal pallidal neuronal activity during mild drug-related dyskinesias in Parkinson's disease: decreased firing rates and altered firing patterns. J Neurophysiol 2007;97:2627-2641.
28.
Foffani G, Ardolino G, Meda B, Egidi M, Rampini P, Caputo E, Baselli G, Priori A: Altered subthalamo-pallidal synchronisation in parkinsonian dyskinesias. J Neurol Neurosurg Psychiatry 2005;76:426-428.
29.
Silberstein P, Oliviero A, Di Lazzaro V, Insola A, Mazzone P, Brown P: Oscillatory pallidal local field potential activity inversely correlates with limb dyskinesias in Parkinson's disease. Exp Neurol 2005;194:523-529.
30.
Alonso-Frech F, Zamarbide I, Alegre M, Rodriguez-Oroz MC, Guridi J, Manrique M, Valencia M, Artieda J, Obeso JA: Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain 2006;129:1748-1757.
31.
Brown P, Eusebio A: Paradoxes of functional neurosurgery: clues from basal ganglia recordings. Mov Disord 2008;23:12-20; quiz 158.
32.
Peppe A, Pierantozzi M, Altibrandi MG, Giacomini P, Stefani A, Bassi A, Mazzone P, Bernardi G, Stanzione P: Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulation. Eur J Neurol 2001;8:579-586.
33.
Durif F, Lemaire JJ, Debilly B, Dordain G: Long-term follow-up of globus pallidus chronic stimulation in advanced Parkinson's disease. Mov Disord 2002;17:803-807.
34.
Rodrigues JP, Walters SE, Watson P, Stell R, Mastaglia FL: Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease. Mov Disord 2007;22:1866-1870.
35.
Rodrigues JP, Walters SE, Watson P, Stell R, Mastaglia FL: Globus pallidus stimulation in advanced Parkinson's disease. J Clin Neurosci 2007;14:208-215.
36.
McCairn KW, Turner RS: Deep brain stimulation of the globus pallidus internus in the parkinsonian primate: local entrainment and suppression of low-frequency oscillations. J Neurophysiol 2009;101:1941-1960.
37.
Cleary DR, Raslan AM, Rubin JE, Bahgat D, Viswanathan A, Heinricher MM, Burchiel KJD: Deep brain stimulation entrains local neuronal firing in human globus pallidus internus. J Neurophysiol 2013;109:978-987.
38.
McConnell GC, So RQ, Hilliard JD, Lopomo P, Grill WM: Effective deep brain stimulation suppresses low-frequency network oscillations in the basal ganglia by regularizing neural firing patterns. J Neurosci 2012;32:15657-15668.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.